Why has phage therapy not yet become the standard of treatment in the world?
Phage therapy—a method of treating bacterial infections using bacteriophages—is considered a potential solution to the problem of antibiotic resistance. However, due to numerous legal, scientific, and organizational barriers, it has not yet become a part of global medical practice. This article examines in detail the main reasons for this phenomenon: from patenting issues and the lack of a regulatory framework to mistrust in the medical community and the complexity of clinical trials.